Pharmaceutical Intervention in the Pharmacological Therapy of Elderly Patients in San Luis-ECUADOR

Main Article Content

Aida Miranda https://orcid.org/0000-0002-5625-9754
Danny Ortega https://orcid.org/0000-0003-4407-248X
Paola Caiza https://orcid.org/0000-0002-8785-3545
Gisela Pilco https://orcid.org/0000-0002-4132-8905

Keywords

Pharmaceutical intervention, elderly patients, MRP

Abstract

Population’s aging leads to a frequent usage of pharmaceutical medications to treat or control various ailments because of aging, increasing the probability of occurrence of problems related to its usage. The primary objective of this study was to conduct pharmaceutical interventions in elderly patients from San Luis – Riobamba, using surveys to identify the sociodemographic characteristics, diseases, and medicines usage. Once the problems related to pharmacological therapy were identified, pharmaceutical interventions were carried our prior the acceptance of each patient. The study had the participation of 422 elderly patients, with the prevalence of females (59.7%), aged between 60 and 70 years (45.5%); we identified that 82.5% of the elderly patients have diseases, finding that joint pain such as Arthritis/Osteoarthritis has the higher incidence (38.8%), and 50% of the surveyed people consume medication to treat the disease. 40.28% (n=170) of the participants conciliate the treatment review to identify any medication-related problem (MRP), finding interactions (21.2%) and adverse effects probability (21.2%), starting from the PRM identified, 170 pharmaceutical interventions were conducted, considering as priority (67.6%) the education on non-pharmacological measures. The pharmaceutical interventions done through the study benefited the elderly patients and will contribute to reduce the appearance of PRM.

Abstract 1439 | PDF Downloads 653

References

1. Dagnew SB, Mekonnen GB, Zeleke EG, et al. Clinical Pharmacist Intervention on Drug-Related Problems among Elderly Patients Admitted to Medical Wards of Northwest Ethiopia Comprehensive Specialized Hospitals: A Multicenter Prospective,
Observational Study. Biomed Res Int. 2022. https://doi.org/10.1155/2022/8742998
2. Ma Z, Sun S, Zhang C, et al. Characteristics of drug-related problems and pharmacists’ interventions in a geriatric unit in China. International Journal of Clinical Pharmacy. 2021;43:270-4. https://doi.org/10.1007/s1109 6-020-01128-8
3. Niveditha TV, Pradhan A, Shabaraya AR, et al. Drug Related Problems in Geriatric Patients with Inappropriate Medication Use. International Journal of Research and Review. 2021;8(5):487-96. https://doi.org/10.52403/ijrr.20210559
4. Delgado-Silveira E, Fernández-Villalba EM, Freire MGM, et al. The impact of Pharmacy Intervention on the treatment of elderly multi-pathological patients. Farmacia Hospitalaria. 2015;39(4):192-202. https://doi.org/10.7399/fh.2015.39.4.8329
5. Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ Canadian Medical Association Journal. 2003;169(1):17-22. https://doi.org/10.1257/rct.1516-
1.0
6. Varela L. Principios de geriatría y gerontología. Universidad Peruana Cayetano Heredia, Lima; 2011;2:251-261. 
7. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging. 2005;22(1):69-82. https://doi.org/10.2165/00002512-200522010-00005
8. Wauters M, Elserviers M, Vaes B, et al. Mortality, hospitalisation, institutionalisation in community-dwelling oldest old: The impact of medication. Arch Gerontol Geriatr. 2016; 65:9-16. https://doi.org/10.1016/j.archger.2016.02.009
9. Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. BMC Pharmacol Toxicol. 2017;18(1). https://doi.org/10.1186/s40360-017-0157-2
10. Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257-65. https://doi.org/10.1046/j.1365-2125.2001.00347.x
11. Falcón DG, Lores-Delgado D, Dupotey-Varela NM, et al. Atención Farmacéutica en adultos mayores hipertensos. Una experiencia en la atención primaria de salud en Cuba. Ars Pharmaceutica (Internet). 2018;59(2):91-8. https://dx.doi.org/10.30827/ars.
v59i2.7307
12. Hernadez DS, Castro MS, Dader MJF. Programa DADER. Seguimiento Farmacoterapéutico. 2007. 
13. Ferreira C, García K, Macías L, et al. MUJERES Y HOMBRES del Ecuador en Cifras III. Instituto Nacional de Estadísticas y Censos. 2009.
14. González Ó. A propósito del Covid-19. El rol de la edad y género en la inmunidad. Rev Hosp Clin Univ Chile. 2020;189-97. https://www.redclinica.cl/Portals/0/Users/014/14/14/1907.pdf
15. Guevara A. Frecuencia de atenciones realizadas en el servicio de medicina general, según sexo, en el distrito de Villa El Salvador, Lima-Perú. Horiz Med. 2022. https://doi.org/10.24265/horizmed.2022.v22n2.09
16. Figueroa Y, Lasso CI, Gómez E, et al. Physical condition in older adults for elderly groups in Cali (Colombia). Fisioterapia. 2019;41(6):314-21. https://doi.org/10.1016/j.ft.2019.07.005
17. Carrera P, Aguilar I, Clemente E, et al. Consumo de medicamentos en población adulta: influencia del autoconsumo. Aten Primaria. 2013;45(10):528-35. https://doi.org/10.1016%2Fj.aprim.2013.05.006
18. Baca J. Acompañamiento al adulto mayor enfermo. Matriti. 2014.
19. Pérez M. Artritis y artrosis. Farmacia Profesional. 2003;17. https://www.elsevier.es/es-revista-farmacia-profesional-3-articuloartritis- artrosis-13056238
20. Matute M, Montero A. Review of the pharmacological treatment of osteoarthritis pain with paracetamol, non-steroid anti-inflammatory (NSAIDSS) and selective cyclooxygenase-2 inhibitors (COXIB). Revista de la Sociedad Española del Dolor.
2021;28:43-8. https://doi.org/10.20986/resed.2021.3864/2020
21. Córdova V, Chávez H, Varela L, et al. Características de la prescripción farmacológica en pacientes adultos mayores hospitalizados. Diagnóstico. 2005;44(4):1511-159.
22. Ortiz P, Juárez M, Valdivia L. Hospitalización por eventos adversos relacionados a medicamentos en adultos mayores. Rev Soc Peru Med Interna. 2009;22(2):53-6.
23. Oscanoa T. Diagnóstico de problemas relacionados con medicamentos en adultos mayores al ser hospitalizados. Rev Peru Med Exp Salud Pública. 2011;28(2):256-63.
24. Falcón DG, Delgado DL, Varela NMD, et al. Problemas relacionados con medicamentos en adultos mayores hipertensos. Pharmaceutical Care España. 2021;23(3):219-35.
25. Plácido AI, Herdeiro MT, Morgado M, et al. Drug-related Problems in Home-dwelling Older Adults: A Systematic Review. Clin Ther. 2020;42(4):559-572. https://doi.org/10.1016/j.clinthera.2020.02.005
26. Casas - Vásquez P, Ortiz - Saavedra P, et al. ESTRATEGIAS PARA OPTIMIZAR EL MANEJO FARMACOLÓGICO EN EL ADULTO MAYOR. Rev Peru Med Exp Salud Publica. 2016;33(2):335-41. http://dx.doi.org/10.17843/rpmesp.2016.332.2153
27. Hailu BY, Berhe DF, Gudina EK, et al. Drug related problems in admitted geriatric patients: The impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(1):1-8. https://doi.org/10.1186/s12877-020-1413-7

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>